News Headlines Article

Unfair Practices Claim Against Quest May Stick
Courthouse News Service

A group of labs can advance a class action accusing Quest Diagnostics of conspiring to monopolize the biological-testing market, a federal judge ruled.

Rheumatology Diagnostics Laboratory (RDL), Pacific Breast Pathology Medical Corporation (PBP), Hunter Laboratories and Surgical Pathology Associates (SPA) first filed the antitrust complaint in November 2012 against Aetna, Blue Shield of California Life & Health Insurance, Blue Cross and Blue Shield Association, and Quest Diagnostics.